ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE
Patent Owner
Stats
- 25 US PATENTS IN FORCE
- 5 US APPLICATIONS PENDING
- Feb 22, 2018 most recent publication
Details
- 25 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 279 Total Citation Count
- Nov 12, 2002 Earliest Filing
- 10 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0052,171 KITS FOR DETERMINING MALE FERTILITY BY MEASURING LEVELS OF A2V-ATPASE, G-CSF, MIP 1 ALPHA, MCP-1, AND METHODS AND KITS FOR IMPROVING REPRODUCTIVE OUTCOMES IN ARTIFICIAL INSEMINATION PROCEDURESAug 30, 17Feb 22, 18[G01N]
2017/0042,989 PHOTOSENSITIZED TRYPANOSOMATIDS AND VACCINE COMPOSITIONS THEREOFAug 11, 16Feb 16, 17[A61K]
2016/0244,832 METHODS AND KITS FOR DIAGNOSING, PROGNOSING AND MONITORING PARKINSON'S DISEASESep 30, 15Aug 25, 16[C12Q]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9840709 Antisense compounds targeting genes associated with cystic fibrosisFeb 17, 16Dec 12, 17[C12N]
9840710 Antisense compounds targeting leucine-rich repeat kinase 2 (LRRK2) for the treatment of parkinsons diseaseNov 11, 16Dec 12, 17[C07H, A61K, C12N]
9753042 Kits for determining male fertility by measuring levels of a2V-ATPase, G-CSF, MIP 1 alpha, MCP-1, and methods and kits for improving reproductive outcomes in artificial insemination proceduresApr 22, 14Sep 05, 17[G01N]
9725429 Furanyl-imine and thiofuranyl-imine compounds for stabilizing ryanodine receptors from aberrant levels of calcium releaseMay 19, 15Aug 08, 17[C07D]
9556434 Antisense oligonucleotides that target a cryptic splice site in Ush1c as a therapeutic for usher syndromeMay 06, 15Jan 31, 17[C07H, A61K, C12N]
9532961 Method and kit for administering γ-glutamyl-D-cysteine for the prevention of reperfusion injury following ischemic strokeApr 23, 13Jan 03, 17[A61K]
9353371 Antisense compounds targeting genes associated with usher syndromeMay 02, 12May 31, 16[C12N]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2014/0243,388 ANTISENSE OLIGONUCLEOTIDES THAT TARGET A CRYPTIC SPLICE SITE IN USH1C AS A THERAPEUTIC FOR USHER SYNDROMEAbandonedFeb 10, 14Aug 28, 14[C12N]
2014/0154,685 METHOD AND KIT FOR MEASURING MICRO-RNA IN BODY FLUIDSAbandonedDec 03, 12Jun 05, 14[C12Q]
2012/0165,389 ANTISENSE OLIGONUCLEOTIDES THAT TARGET A CRYPTIC SPLICE SITE IN USH1C AS A THERAPEUTIC FOR USHER SYNDROMEAbandonedOct 20, 11Jun 28, 12[A61K]
2012/0129,188 CIRCULATING CYTOCHROME C AS BIOMARKER OF REPERFUSION INJURY AND RESPONSIVENESS TO MITOCHONDRIAL TARGETED INTERVENTIONSAbandonedNov 04, 11May 24, 12[G01N]
2010/0048,722 FORMATION OF ACCUMBENS GluR2-LACKING AMPA RECEPTORS MEDIATES INCUBATION OF COCAINE CRAVINGAbandonedMay 22, 09Feb 25, 10[A61K, A61P]
2009/0047,280 Antibody inhibiting infection of papillomavirusAbandonedJan 07, 08Feb 19, 09[A61K, C12N, A61P, C07K]
7211257 Methods for inducing apoptosis in ovarian carcinoma cells using an anti-regeneration and tolerance factor antibodyExpiredFeb 09, 04May 01, 07[A61K]
2007/0087,376 Splice variants of pre-mRNA transcripts as biomarkers in idiopathic neurodegenerative diseasesAbandonedDec 18, 06Apr 19, 07[C07H, C12Q]
2006/0057,624 Alternatively spliced pre-mRNA transcripts in neurodegenerative diseaseAbandonedAug 30, 05Mar 16, 06[C12Q]
2004/0107,345 System and methodology providing automation security protocols and intrusion detection in an industrial controller environmentAbandonedSep 12, 03Jun 03, 04[H04L, G06F]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.